NCT03409796View on ClinicalTrials.gov

Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge

NACompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

April 24, 2018

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions

Celiac Disease

Interventions

DIETARY_SUPPLEMENT

Gluten

Gluten powder.

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY